ICU Medical, Inc.
ICU Medical, Inc. (ICUI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
icui · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for ICU Medical, Inc. (ICUI) measures how much investors pay for each dollar of the company's trailing earnings. ICUI's current PE ratio of 73.37x is calculated by dividing its stock price of $138.30 by its TTM earnings per share of $1.87. −92.8% discount vs 5Y avg 1022.7x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 17 fiscal years · Front-end computedMinQ1 · 25%37.8x
MedianQ3 · 75%4802.4x
Max
At 73.37x, ICUI's current P/E is higher than in 88% of its annual fiscal year readings over the past 17 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
ICU Medical, Inc.You ICUI | $3.5B | 73.37x | +255.4% | $1.87 |
 Arcutis Biotherapeutics, Inc. ARQT | $2.7B | N/A | — | -$0.13 |
 Haemonetics Corporation HAE | $3.4B | 26.20x | +26.9% | $2.06 |
 Heartflow, Inc. Common Stock HTFL | $2.4B | N/A | — | -$0.32 |
 Disc Medicine, Inc. IRON | $2.5B | N/A | — | -$6.01 |
 LivaNova PLC LIVN | $4.2B | N/A | — | -$4.45 |
 Prestige Consumer Healthcare Inc. PBH | $2.2B | 15.09x | -26.9% | $3.93 |
Industry Average 2 peers with valid PE | — | 20.65x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 4802.44x | $0.03 | — | |
2024-12-31 FY2024 | — | $-4.83 | — | |
2023-12-31 FY2023 | — | $-1.23 | — | |
2022-12-31 FY2022 | — | $-3.11 | — | |
2021-12-31 FY2021 | 48.80x | $4.86 | -5.5% | |
2020-12-31 FY2020 | 51.62x | $4.16 | +35.1% | |
2019-12-31 FY2019 | 38.21x | $4.90 | -77.8% | |
2018-12-31 FY2018 | 172.27x | $1.33 | +179.1% | |
2017-12-31 FY2017 | 61.72x | $3.50 | +63.4% | |
2016-12-31 FY2016 | 37.76x | $3.90 | -5.0% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for ICU Medical, Inc. (ICUI) measures how much investors pay for each dollar of the company's trailing earnings. ICUI's current PE ratio of 73.37x is calculated by dividing its stock price of $138.30 by its TTM earnings per share of $1.87.
Frequently asked questions
ICUI pe ratio · 6 questionsICUI's current PE ratio is 73.37x as of 2026-06-08, based on a stock price of $138.30 and TTM EPS of $1.87. Data sourced from Financial Modeling Prep via ICUI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ICU Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08